Nucleostemin exerts anti-apoptotic function via p53 signaling pathway in cardiomyocytes

被引:0
|
作者
Chi Zhang
Jiahai Shi
Long Qian
Chao Zhang
Kunpeng Wu
Chen Yang
Daliang Yan
Xiang Wu
Xiaojuan Liu
机构
[1] Affiliated Hospital of Nantong University,Department of Cardiology
[2] Affiliated Hospital of Nantong University,Department of Thoracic Surgery
[3] Nantong University,Department of Pathogen Biology, Medical College
[4] Nantong University,Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Medical College
关键词
Nucleostemin; Apoptosis; p53; Myocardial ischemia reperfusion;
D O I
暂无
中图分类号
学科分类号
摘要
Cardiomyocytes apoptosis following reperfusion injury causes irreversible damage to cardiac function. Understanding the mechanisms underlying cardiomyocytes death under these conditions can be helpful to identify strategies to abrogate such detrimental effects. Stem cell-specific proteins and regulatory pathways become important in understanding reparative processes in the myocardium. One such regulatory protein named nucleostemin (NS) has vital roles in cardiac ischemia. Although the relationship between NS and cell apoptosis has been studied, it is unknown how NS is controlled and how it participates in cardiomyocytes apoptosis induced by ischemia reperfusion (I/R). In the present study, we aimed to investigate the direct role of NS in myocardial I/R. In vivo, NS was highly expressed in cardiac tissues after I/R. Double immunofluorescent staining showed that NS located in the nucleolar of cardiomyocytes and correlated with cardiomyocytes apoptosis. Furthermore, in vitro primary rat cardiomyocytes increased NS expression induced by hypoxia-reoxygenation (H/R) treatment, in line with results in vivo. Suppression of NS expression by siNS promoted the expression of terminal deoxynucleotide transferase-mediated dUTP nick end labeling (TUNEL)-positive cells p53 and cleaved caspase-3, which demonstrates I/R may require increased expression of NS to suppress p53 activation and maintain cardiomyocytes survival.
引用
收藏
页码:1064 / 1071
页数:7
相关论文
共 50 条
  • [31] Troglitazone acutely activates multiple signaling pathways and exhibits anti-apoptotic effects in cardiomyocytes
    Lee, WL
    Wu, W
    Navarrete, R
    Chen, DB
    Wang, PH
    DIABETES, 1999, 48 : A331 - A331
  • [32] Fucoxanthin attenuates doxorubicin-induced cardiotoxicity via anti-oxidant and anti-apoptotic mechanisms associated with p38, JNK and p53 pathways
    Zhao, Yu-Qin
    Zhang, Lun
    Zhao, Guo-Xu
    Chen, Yin
    Sun, Kun-Lai
    Wang, Bin
    JOURNAL OF FUNCTIONAL FOODS, 2019, 62
  • [33] Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions
    Khan, Haroon
    Reale, Marcella
    Ullah, Hammad
    Sureda, Antoni
    Tejada, Silvia
    Wang, Ying
    Zhang, Zhang-Jin
    Xiao, Jianbo
    BIOTECHNOLOGY ADVANCES, 2020, 38
  • [34] Silencing of Dicer1 temporally separates pro- and anti-apoptotic signaling and confers susceptibility to chemotherapy in p53 mutated cells
    Nekova, Tatyana S.
    Kneitz, Susanne
    Einsele, Hermann
    Stuhler, Gernot
    CELL CYCLE, 2014, 13 (14) : 2192 - 2198
  • [35] RB regulates the stability and the apoptotic function of p53 via MDM2
    Hsieh, JK
    Chan, FSG
    O'Connor, DJ
    Mittnacht, S
    Zhong, S
    Lu, X
    MOLECULAR CELL, 1999, 3 (02) : 181 - 193
  • [36] A balance between NF-Y and p53 governs the pro- and anti-apoptotic transcriptional response
    Benatti, Paolo
    Basile, Valentina
    Merico, Daniele
    Fantoni, Luca Isaia
    Tagliafico, Enrico
    Imbriano, Carol
    NUCLEIC ACIDS RESEARCH, 2008, 36 (05) : 1415 - 1428
  • [37] Depletion of the nucleolar protein nucleostemin causes g1 cell cycle arrest via the p53 pathway
    Ma, Hanhui
    Pederson, Thoru
    MOLECULAR BIOLOGY OF THE CELL, 2007, 18 (07) : 2630 - 2635
  • [38] No anti-apoptotic effects of single copies of mutant p53 genes in drug-treated tumor cells
    Fritzsche, C
    Zeller, G
    Knaup, KX
    Roemer, K
    ANTI-CANCER DRUGS, 2004, 15 (07) : 679 - 688
  • [39] The anti-apoptotic role for p53 following exposure to ultraviolet light does not involve DDB2
    Stubbert, L. J.
    Smith, J. M.
    Hamill, J. D.
    Arcand, T. L.
    McKay, B. C.
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 663 (1-2) : 69 - 76
  • [40] The chemopreventive activity of the butyric acid prodrug tributyrin in experimental rat hepatocarcinogenesis is associated with p53 acetylation and activation of the p53 apoptotic signaling pathway
    de Conti, Aline
    Tryndyak, Volodymyr
    Koturbash, Igor
    Heidor, Renato
    Kuroiwa-Trzmielina, Joice
    Ong, Thomas P.
    Beland, Frederick A.
    Moreno, Fernando S.
    Pogribny, Igor P.
    CARCINOGENESIS, 2013, 34 (08) : 1900 - 1906